In addition, negative MRP-1/CD9 expression was associated with a poor prognosis in breast cancer (Miyake et al, 1996), lung cancer (Higashiyama et al, 1995) and pancreatic cancer (Sho et al, 1998). This evidence concerns the gene CD9 and breast cancer.